Results 21 to 30 of about 4,026 (283)
Pharmaceutical errors while manufacturing medicines in pharmacies [PDF]
Вестник Витебского государственного медицинского университета, 2022 Pharmaceutical errors, as a separate category of medical errors, inflict moral and physical suffering on patients and are a heavy burden of guilt and proceedings for workers who have made them in their work.
S.S. Malchenkova, N.S. Golyak
doaj +1 more source
Prevalence, determinants, and characteristics of extemporaneous compounding in Jordanian pharmacies
BMC Health Services Research, 2019 Background Pharmaceutical compounding is an essential component in pharmacy practice allowing pharmacists to provide dosage forms or strengths that are commercially unavailable. Medications compounded for patient-specific needs contribute to personalized
Hatim S. AlKhatib +5 more
doaj +1 more source
Compounding in community pharmacy
Australian Prescriber, 2008 When a drug is not available, or is unavailable in a form suitable for a particular patient, compounding may provide...
Romano A Fois +3 more
openaire +2 more sources
Hazardous drugs levels in compounding area surfaces of Hospital Pharmacies Services: multicentric study [PDF]
Farmacia Hospitalaria, 2018 Objective: Hazardous drugs presence at Hospital Pharmacies has been demonstrated in numerous studies. This study aims to analyze the presence and levels of hazardous drugs at Spanish Hospital Pharmacies and the influence of different aspects on them ...
José Luis Poveda-Andrés +1 more
doaj +1 more source
Brazilian Journal of Biology, 2021 As there is a great scarcity of studies on the importance of good compounding practices in the preparation of cosmetics, this study aimed to evaluate the quality control of cosmetics with active ingredient caffeine for the treatment of cellulite prepared
E. M. Vogel +4 more
doaj +1 more source
Medicina, 2019 Background and objectives: Extemporaneous preparations are pharmaceutical preparations individually prepared for a specific patient or patient group, but also high-risk products accompanied by doubts regarding their safety and quality.
Olga Kiseļova +3 more
doaj +1 more source
RETRACTED: Extemporaneous Compounding: Selective Pharmacists with Separate Skill
INNOVATIONS in Pharmacy, 2019 This article has been retracted: please see INNOVATIONS in pharmacy retraction policy (https://pubs.lib.umn.edu/index.php/innovations/policies). This article has been retracted by the Editor and Publisher due to the inappropriate use of previously ...
AK Mohiuddin
doaj +1 more source
Scientia Pharmaceutica, 2021 The potential therapeutic benefit of transdermal delivery systems for some active pharmaceutical ingredients (APIs) has been well-established for decades within the scientific community. However, together with the clinical efficacy, there is the need for
Hudson Polonini +2 more
doaj +1 more source
Sphingomonas paucimobilis Bloodstream Infections Associated with Contaminated Intravenous Fentanyl
Emerging Infectious Diseases, 2009 Nationally distributed medications from compounding pharmacies, which typically adhere to less stringent quality-control standards than pharmaceutical manufacturers, can lead to multistate outbreaks.
Lisa L. Maragakis +8 more
doaj +1 more source
Journal of Pharmaceutical Analysis, 2018 Meloxicam (MLX) is an anti-inflammatory drug susceptible to variations and crystalline transitions. In compounding pharmacies, the complete crystallographic evaluation of the raw material is not a routine procedure.
Luciana F.A. Romani +9 more
doaj +1 more source